Abstract:To evaluate the impact of varied maternal choline intake on indicators of maternal and fetal well-being, a 12-week controlled feeding study was conducted. Healthy pregnant women (n=26, 27wk gestation) were randomized to controlled choline intakes of 480 (~ choline Adequate Intake) or 930 mg/day. Fasting maternal blood, placental tissue and umbilical cord venous blood were collected. A higher choline intake increased maternal plasma choline (P=0.047), betaine (P=0.011) and dimethylglycine (DMG) (P=0.068). Fetal plasma DMG (P=0.02) and the ratio of DMG to betaine (P=0.001) were also elevated in the 930 mg/d intake group. A higher choline intake altered products of the hypothalamic-pituitary- adrenal (HPA) axis with lower fetal plasma levels of cortisol (56%, P=0.06) and cortisone (74%, P=0.02) as well as higher levels of dehydroepiandrosterone sulfate (DHEAS) (140%, P=0.05). A higher choline intake also tended to increase (P=0.064) promoter region methylation of placental corticotropin-releasing hormone (CRH) (the key regulator of HPA axis activity) and to decrease (P=0.097) its mRNA levels. These data show that a maternal choline intake exceeding the choline AI increases the availability of labile methyl groups and decreases fetal indicators of stress-responsive HPA axis activity (i.e. cortisol, CRH) probably through epigenetic mechanisms. Grant Funding Source: Funded in part by USDA, ENC and the Beef Checkoff through NCBA

Fetal Stress Markers Are Lowered by Maternal Choline Intakes Exceeding Recommendations